Article    Table of Contents                    Full Text of this article Free    Figures/Tables List  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  Google Scholar    Search for Related Content  PubMed Articles in PubMed by Author:    Savage, P. J.    Related Articles in PubMed    PubMed Citation    PubMed

ONGOING AND PROPOSED TRIALS

Cardiovascular Complications of Diabetes Mellitus: What We Know and What We Need To Know about Their Prevention

Peter J. Savage, MD

1 January 1996 | Volume 124 Issue 1 Part 2 | Pages 123-126

Cardiovascular disease is a major cause of morbidity and mortality in patients with non–insulin-dependent diabetes mellitus (NIDDM). With an increase in the number of older diabetic persons, an increase in U.S. minority populations with high rates of diabetes, and the proven success of new methods to reduce microvascular complications, the importance of diabetic macrovascular complications will increase. The relative effectiveness of different treatments to reduce the incidence of diabetic cardiovascular complications is poorly understood. In addition to relative efficacy, issues related to patient burden and the economic cost of different treatments must be considered. Some of the information needed to improve therapy will be available soon from ongoing clinical trials. Obtaining definitive answers to other questions, especially those related to the relative benefit of intensive glucose level control compared with control of other known cardiovascular disease risk factors, will require additional studies. Although several questions unique to diabetic patients remain unanswered, results of previous clinical trials done among largely nondiabetic participants can be used to develop interim recommendations for cardiovascular disease prevention. Until definitive guidelines for prevention are established, combining aggressive therapy for known cardiovascular disease risk factors with efforts to normalize the glucose level offers the best chance to reduce the higher risk for cardiovascular disease associated with NIDDM.

Author and Article Information

From the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland. For the current author address, see end of text.
Note: This article is one of a series of articles comprising an Annals of Internal Medicine supplement entitled "Risks and Benefits of Intensive Management in Non-Insulin-dependent Diabetes Mellitus: The Fifth Regenstrief Conference." To view a complete list of the articles included in this supplement, please view its Table of Contents.
Requests for Reprints: Peter J. Savage, MD, Epidemiology and Biometry Program, DECA, Two Rockledge Center-Rm 8154, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Bethesda, MD 20892-7934.

This article has been cited by other articles:

				R. Scognamiglio, C. Negut, A. Ramondo, A. Tiengo, and A. Avogaro Detection of Coronary Artery Disease in Asymptomatic Patients With Type 2 Diabetes Mellitus J. Am. Coll. Cardiol., January 3, 2006; 47(1): 65 - 71. [Abstract] [Full Text] [PDF]

				G. X. Brogan Jr, E. D. Peterson, J. Mulgund, D. L. Bhatt, E. M. Ohman, W. B. Gibler, C. V. Pollack Jr, M. E. Farkouh, and M. T. Roe Treatment Disparities in the Care of Patients With and Without Diabetes Presenting With Non-ST-Segment Elevation Acute Coronary Syndromes Diabetes Care, January 1, 2006; 29(1): 9 - 14. [Abstract] [Full Text] [PDF]

				R. Scognamiglio, C. Negut, A. Ramondo, A. Tiengo, and A. Avogaro Detection of Coronary Artery Disease in Asymptomatic Patients With Type 2 Diabetes Mellitus J. Am. Coll. Cardiol., December 13, 2005; (2005) j.jacc.2005.10.008v1. [Abstract] [Full Text] [PDF]

				B. E.K. Klein, R. Klein, P. E. McBride, S. E. Moss, R. J. Prineas, and J. O. Reinke Electrocardiographic Abnormalities in Individuals With Long-Duration Type 1 Diabetes Diabetes Care, January 1, 2005; 28(1): 145 - 147. [Full Text] [PDF]

				T.-M. Lee and T.-F. Chou Impairment of Myocardial Protection in Type 2 Diabetic Patients J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 531 - 537. [Abstract] [Full Text] [PDF]

				W. A. Hsueh and R. E. Law PPAR{gamma} and Atherosclerosis: Effects on Cell Growth and Movement Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 1891 - 1895. [Abstract] [Full Text] [PDF]

				A. R. Collins, W. P. Meehan, U. Kintscher, S. Jackson, S. Wakino, G. Noh, W. Palinski, W. A. Hsueh, and R. E. Law Troglitazone Inhibits Formation of Early Atherosclerotic Lesions in Diabetic and Nondiabetic Low Density Lipoprotein Receptor-Deficient Mice Arterioscler. Thromb. Vasc. Biol., March 1, 2001; 21(3): 365 - 371. [Abstract] [Full Text] [PDF]

				D.K McGuire, H Emanuelsson, C.B Granger, E Magnus Ohman, D.J Moliterno, H.D White, D Ardissino, J.W Box, R.M Califf, and E.J Topol Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb Study Eur. Heart J., November 1, 2000; 21(21): 1750 - 1758. [Abstract] [PDF]

				N Suskin, R.S McKelvie, R.J Burns, R Latini, D Pericak, J Probstfield, J.L Rouleau, C Sigouin, C.B Solymoss, R Tsuyuki, et al. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure Eur. Heart J., August 2, 2000; 21(16): 1368 - 1375. [Abstract] [PDF]

				J. W Anderson, L. D Allgood, J. Turner, P. R Oeltgen, and B. P Daggy Effects of psyllium on glucose and serum lipid responses in men with type 2 diabetes and hypercholesterolemia Am. J. Clinical Nutrition, October 1, 1999; 70(4): 466 - 473. [Abstract] [Full Text] [PDF]

				W. J. de Grauw, E. H van de Lisdonk, R. R. Behr, W. H. van Gerwen, H. J. van den Hoogen, and C. van Weel The impact of type 2 diabetes mellitus on daily functioning Fam. Pract., April 1, 1999; 16(2): 133 - 139. [Abstract] [Full Text] [PDF]

				Y. Hattori, S. Hattori, and K. Kasai Troglitazone Upregulates Nitric Oxide Synthesis in Vascular Smooth Muscle Cells Hypertension, April 1, 1999; 33(4): 943 - 948. [Abstract] [Full Text] [PDF]

				A. J Krentz Fortnightly Review: Insulin resistance BMJ, November 30, 1996; 313(7069): 1385 - 1389. [Abstract] [Full Text]